http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3565552-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cdd6c9aa2a56078633fd99c1537ae
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
filingDate 2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe64666db44e191aef120b9eab3ed435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb8088d733ca6d5f82a6a1de1c2aa34b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3c2ef92912e29936eb92b9f8631bd2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33f3d873c54ed8ec0286e6de271ab0a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d2428a3f6411d2782c0943f882eec3
publicationDate 2019-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3565552-A1
titleOfInvention An improved process for the preparation of rivaroxaban involving novel intermediate
abstract The present invention relates to the novel key intermediate, 4-{4-[(5S)-(Aminomethyl)-2- oxo-l,3-oxazolidin-3-yl]-phenyl}-morpholin-3-one perchlorate, in the synthesis of rivaroxaban. The invention further relates to the crystalline form of novel intermediate, the process to prepare the novel intermediate and method of preparing rivaroxaban using this novel intermediate. The invention provides an improved and efficient process for preparation of Rivaroxaban.
priorityDate 2017-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9875401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226465373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66836158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135206537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID377110328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11690317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID719412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226793405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21894791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227167337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118348037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226455639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID589223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID311797167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11346837

Total number of triples: 53.